PRA Health Sciences | Sustainability Performance
Provides clinical research and healthcare data solutions, supporting drug development and patient care initiatives.
1976
Ireland
10,001+ employees
Biotechnology
$1B - 10B in revenue
$1B - 10B in profitability
Sustainability Ranking & Industry Benchmark
#5765
Overall#45
in Ireland#112
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Governance
Targets
Controversy level
- PRA Health Sciences (acquired by ICON in 2021 for USD 12 billion), US clinical research organization, has faced multiple US FDA Form 483 observations at clinical trial sites and the historic 2019 USD 5 million SEC settlement over alleged inadequate disclosure of clinical trial site performance affecting institutional shareholders during the acquisition period.
Sustainability targets and commitments
| Target | Year | Value | Scope | Baseline |
|---|
